{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:47:37Z","timestamp":1782089257520,"version":"3.54.5"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T00:00:00Z","timestamp":1777766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["12235004"],"award-info":[{"award-number":["12235004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["12175044"],"award-info":[{"award-number":["12175044"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["12375338, 82173461"],"award-info":[{"award-number":["12375338, 82173461"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cellular dormancy in colorectal cancer (CRC) significantly contributes to therapeutic resistance, tumor recurrence, and metastasis, resulting in poor prognosis. However, the underlying molecular mechanisms remain poorly understood. Here, we used spheroid culture combined with serum deprivation to enrich and identify dormancy-like CRC cells in vitro and characterized their dormancy-like phenotype by G0\/G1 phase arrest, suppressed proliferation and radio-resistance. Compared to proliferative cells, dormancy-like CRC cells maintained similar tumor formation capacity but displayed higher PD-L1 expression level and enhanced migratory ability, indicating greater aggressiveness. Proteomics analysis revealed DDX21 was significantly downregulated in dormancy-like CRC cells, and analysis of clinical data showed an inverse correlation between DDX21 and PD-L1 in CRC patients. This is consistent with the findings that knocking down DDX21 markedly increased PD-L1 levels, suggesting a role for DDX21 in immune evasion. Importantly, overexpressing DDX21 reversed the radio-resistance of dormancy-like CRC cells. Mechanistically, DDX21 downregulation induced a dormancy-like phenotype via p38MAPK activation and AKT suppression to inhibit cellular growth. Furthermore, DDX21 bound to the\n                    <jats:italic>NUCKS1<\/jats:italic>\n                    promoter, and its downregulation reduced NUCKS1 transcription, leading to elevated p27\/p21 levels, which reinforced G0\/G1 arrest. We also identified HERC2 as the E3 ligase mediating DDX21 degradation via K48\/K63-linked polyubiquitination, dependent on the DDX21 helicase core domain. In conclusion, our findings establish DDX21 as a crucial regulator of dormancy-like phenotype in colorectal cancer cells and highlight its potential as a biomarker for dormancy-like tumor populations, radioresistance and poor clinical outcomes in CRC.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-08811-0","type":"journal-article","created":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T20:59:29Z","timestamp":1777841969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ubiquitination of DDX21 by HERC2 induces a dormancy-like phenotype via the NUCKS1-p21\/p27 axis to promote radio-resistance in colorectal cancer cells"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5576-7734","authenticated-orcid":false,"given":"Yuqi","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinglong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4884-6411","authenticated-orcid":false,"given":"Jianghong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9336-9912","authenticated-orcid":false,"given":"Chunlin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4307-3616","authenticated-orcid":false,"given":"Yan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,3]]},"reference":[{"key":"8811_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"8811_CR2","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394:1467\u201380.","journal-title":"Lancet"},{"key":"8811_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.semcancer.2021.04.021","volume":"78","author":"S Basu","year":"2022","unstructured":"Basu S, Dong Y, Kumar R, Jeter C, Tang DG. Slow-cycling (dormant) cancer cells in therapy resistance, cancer relapse and metastasis. Semin Cancer Biol. 2022;78:90\u2013103.","journal-title":"Semin Cancer Biol"},{"key":"8811_CR4","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s43018-020-0088-5","volume":"1","author":"E Risson","year":"2020","unstructured":"Risson E, Nobre AR, Maguer-Satta V, Aguirre-Ghiso JA. The current paradigm and challenges ahead for the dormancy of disseminated tumor cells. Nat Cancer. 2020;1:672\u201380.","journal-title":"Nat Cancer"},{"key":"8811_CR5","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41568-020-0263-0","volume":"20","author":"TG Phan","year":"2020","unstructured":"Phan TG, Croucher PI. The dormant cancer cell life cycle. Nat Rev Cancer. 2020;20:398\u2013411.","journal-title":"Nat Rev Cancer"},{"key":"8811_CR6","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-021-03614-z","volume":"594","author":"AL Correia","year":"2021","unstructured":"Correia AL, Guimar\u00e3es JC, Auf der Maur P, De Silva D, Trefny MP, Okamoto R, et al. Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy. Nature. 2021;594:566\u201371.","journal-title":"Nature"},{"key":"8811_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.canlet.2021.09.037","volume":"524","author":"FC Cackowski","year":"2022","unstructured":"Cackowski FC, Heath EI. Prostate cancer dormancy and recurrence. Cancer Lett. 2022;524:103\u20138.","journal-title":"Cancer Lett"},{"key":"8811_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04606-1","volume":"13","author":"M Zhang","year":"2022","unstructured":"Zhang M, Peng R, Wang H, Yang Z, Zhang H, Zhang Y, et al. Nanog mediated by FAO\/ACLY signaling induces cellular dormancy in colorectal cancer cells. Cell Death Dis. 2022;13:159.","journal-title":"Cell Death Dis"},{"key":"8811_CR9","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210836","volume":"219","author":"BD Khalil","year":"2021","unstructured":"Khalil BD, Sanchez R, Rahman T, Rodriguez-Tirado C, Moritsch S, Martinez AR, et al. An NR2F1-specific agonist suppresses metastasis by inducing cancer cell dormancy. J Exp Med. 2021;219:e20210836.","journal-title":"J Exp Med"},{"key":"8811_CR10","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/s41586-023-05880-5","volume":"616","author":"J Hu","year":"2023","unstructured":"Hu J, S\u00e1nchez-Rivera FJ, Wang Z, Johnson GN, Ho Y-J, Ganesh K, et al. STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma. Nature. 2023;616:806\u201313.","journal-title":"Nature"},{"key":"8811_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s43018-021-00297-3","volume":"3","author":"J Dai","year":"2022","unstructured":"Dai J, Cimino PJ, Gouin KH, Grzelak CA, Barrett A, Lim AR, et al. Astrocytic laminin-211 drives disseminated breast tumor cell dormancy in brain. Nat Cancer. 2022;3:25\u201342.","journal-title":"Nat Cancer"},{"key":"8811_CR12","first-page":"7","volume":"12","author":"M Tufail","year":"2025","unstructured":"Tufail M, Jiang C-H, Li N. Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence. Mil Med Res. 2025;12:7.","journal-title":"Mil Med Res"},{"key":"8811_CR13","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adr3997","volume":"10","author":"S Bakhshandeh","year":"2024","unstructured":"Bakhshandeh S, Heras U, Ta\u00efeb HM, Varadarajan AR, Lissek SM, H\u00fccker SM, et al. Dormancy-inducing 3D engineered matrix uncovers mechanosensitive and drug-protective FHL2-p21 signaling axis. Sci Adv. 2024;10:eadr3997.","journal-title":"Sci Adv"},{"key":"8811_CR14","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/s41586-022-05043-y","volume":"608","author":"Y Ohta","year":"2022","unstructured":"Ohta Y, Fujii M, Takahashi S, Takano A, Nanki K, Matano M, et al. Cell-matrix interface regulates dormancy in human colon cancer stem cells. Nature. 2022;608:784\u201394.","journal-title":"Nature"},{"key":"8811_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112560","volume":"42","author":"DK Singh","year":"2023","unstructured":"Singh DK, Carcamo S, Farias EF, Hasson D, Zheng W, Sun D, et al. 5-Azacytidine- and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-\u03b2-SMAD4 signaling. Cell Rep. 2023;42:112560.","journal-title":"Cell Rep"},{"key":"8811_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature13923","volume":"518","author":"E Calo","year":"2015","unstructured":"Calo E, Flynn RA, Martin L, Spitale RC, Chang HY, Wysocka J. RNA helicase DDX21 coordinates transcription and ribosomal RNA processing. Nature. 2015;518:249\u201353.","journal-title":"Nature"},{"key":"8811_CR17","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.molcel.2019.06.020","volume":"75","author":"DS Kim","year":"2019","unstructured":"Kim DS, Camacho CV, Nagari A, Malladi VS, Challa S, Kraus WL. Activation of PARP-1 by snoRNAs controls ribosome biogenesis and cell growth via the RNA Helicase DDX21. Mol Cell. 2019;75:1270\u201385 e14.","journal-title":"Mol Cell"},{"key":"8811_CR18","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.7150\/jca.69216","volume":"13","author":"P Lu","year":"2022","unstructured":"Lu P, Yu Z, Wang K, Zhai Y, Chen B, Liu M, et al. DDX21 interacts with WDR5 to promote colorectal cancer cell proliferation by activating CDK1 expression. J Cancer. 2022;13:1530\u20139.","journal-title":"J Cancer"},{"key":"8811_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/ncb2008","volume":"12","author":"S Bekker-Jensen","year":"2010","unstructured":"Bekker-Jensen S, Rendtlew Danielsen J, Fugger K, Gromova I, Nerstedt A, Lukas C, et al. HERC2 coordinates ubiquitin-dependent assembly of DNA repair factors on damaged chromosomes. Nat Cell Biol. 2010;12:80\u20136.","journal-title":"Nat Cell Biol"},{"key":"8811_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.659049","volume":"11","author":"NA Mathieu","year":"2021","unstructured":"Mathieu NA, Levin RH, Spratt DE. Exploring the roles of HERC2 and the NEDD4L HECT E3 ubiquitin ligase subfamily in p53 signaling and the DNA damage response. Front Oncol. 2021;11:659049.","journal-title":"Front Oncol"},{"key":"8811_CR21","first-page":"61","volume":"11","author":"H Pan","year":"2021","unstructured":"Pan H, Song Y, Zhang H, Bai Y, Konishi T, Kobayashi A, et al. Radiation engenders converse migration and invasion in colorectal cancer cells through opposite modulation of ANXA2\/AKT\/GSK3beta pathway. Am J Cancer Res. 2021;11:61\u201378.","journal-title":"Am J Cancer Res"},{"key":"8811_CR22","first-page":"10","volume":"763-764","author":"Y Pan","year":"2014","unstructured":"Pan Y, Ye S, Yuan D, Zhang J, Bai Y, Shao C. Hydrogen sulfide (H2S)\/cystathionine gamma-lyase (CSE) pathway contributes to the proliferation of hepatoma cells. Mutat Res. 2014;763-764:10\u20138.","journal-title":"Mutat Res"},{"key":"8811_CR23","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1053\/j.gastro.2017.04.017","volume":"153","author":"H Li","year":"2017","unstructured":"Li H, Rokavec M, Jiang L, Horst D, Hermeking H. Antagonistic effects of p53 and HIF1A on microRNA-34a regulation of PPP1R11 and STAT3 and hypoxia-induced epithelial to mesenchymal transition in colorectal cancer cells. Gastroenterology. 2017;153:505\u201320.","journal-title":"Gastroenterology"},{"key":"8811_CR24","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1093\/nar\/gkn176","volume":"36","author":"S Gotz","year":"2008","unstructured":"Gotz S, Garc\u00eda-G\u00f3mez JM, Terol J, Williams TD, Nagaraj SH, Nueda MJ, et al. High-throughput functional annotation and data mining with the Blast2GO suite. Nucleic Acids Res. 2008;36:3420\u201335.","journal-title":"Nucleic Acids Res"},{"key":"8811_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-15-293","volume":"15","author":"P Bardou","year":"2014","unstructured":"Bardou P, Mariette J, Escudie F, Djemiel C, Klopp C. jvenn: an interactive Venn diagram viewer. BMC Bioinforma. 2014;15:293.","journal-title":"BMC Bioinforma"},{"key":"8811_CR26","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1093\/bioinformatics\/btu097","volume":"30","author":"BG Pierce","year":"2014","unstructured":"Pierce BG, Wiehe K, Hwang H, Kim B-H, Vreven T, Weng Z. ZDOCK server: interactive docking prediction of protein-protein complexes and symmetric multimers. Bioinformatics. 2014;30:1771\u20133.","journal-title":"Bioinformatics"},{"key":"8811_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13046-019-1505-4","volume":"39","author":"F Francescangeli","year":"2020","unstructured":"Francescangeli F, Contavalli P, De Angelis ML, Careccia S, Signore M, Haas TL, et al. A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer. J Exp Clin Cancer Res: CR. 2020;39:2.","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"8811_CR28","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1080\/09553002.2021.1913529","volume":"99","author":"S Hauge","year":"2021","unstructured":"Hauge S, Eek Mariampillai A, R\u00f8dland GE, Bay LTE, Landsverk HB, Sylju\u00e5sen RG. Expanding roles of cell cycle checkpoint inhibitors in radiation oncology. Int J Radiat Biol. 2021;99:941\u201350.","journal-title":"Int J Radiat Biol"},{"key":"8811_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/srep04012","volume":"4","author":"T Oki","year":"2014","unstructured":"Oki T, Nishimura K, Kitaura J, Togami K, Maehara A, Izawa K, et al. A novel cell-cycle-indicator, mVenus-p27K-, identifies quiescent cells and visualizes G0-G1 transition. Sci Rep. 2014;4:4012.","journal-title":"Sci Rep"},{"key":"8811_CR30","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ccell.2023.12.011","volume":"42","author":"ET Goddard","year":"2024","unstructured":"Goddard ET, Linde MH, Srivastava S, Klug G, Shabaneh TB, Iannone S, et al. Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapies. Cancer Cell. 2024;42:119\u201334. e12.","journal-title":"Cancer Cell"},{"key":"8811_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7170","volume":"6","author":"MS Sosa","year":"2015","unstructured":"Sosa MS, Parikh F, Maia AG, Estrada Y, Bosch A, Bragado P, et al. NR2F1 controls tumour cell dormancy via SOX9- and RAR\u03b2-driven quiescence programmes. Nat Commun. 2015;6:6170.","journal-title":"Nat Commun"},{"key":"8811_CR32","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1158\/0008-5472.CAN-17-1051","volume":"78","author":"LY Yu-Lee","year":"2018","unstructured":"Yu-Lee LY, Yu G, Lee YC, Lin SC, Pan J, Pan T, et al. Osteoblast-secreted factors mediate dormancy of metastatic prostate cancer in the bone via activation of the TGFbetaRIII-p38MAPK-pS249\/T252RB pathway. Cancer Res. 2018;78:2911\u201324.","journal-title":"Cancer Res"},{"key":"8811_CR33","doi-asserted-by":"publisher","first-page":"6102","DOI":"10.3390\/ijms21176102","volume":"21","author":"G Maik-Rachline","year":"2020","unstructured":"Maik-Rachline G, Lifshits L, Seger R. Nuclear P38: roles in physiological and pathological processes and regulation of nuclear translocation. Int J Mol Sci. 2020;21:6102.","journal-title":"Int J Mol Sci"},{"key":"8811_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27124-8","volume":"12","author":"S Hume","year":"2021","unstructured":"Hume S, Grou CP, Lascaux P, D\u2019Angiolella V, Legrand AJ, Ramadan K, et al. The NUCKS1-SKP2-p21\/p27 axis controls S phase entry. Nat Commun. 2021;12:6959.","journal-title":"Nat Commun"},{"key":"8811_CR35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41580-022-00542-2","volume":"24","author":"JNS Vargas","year":"2023","unstructured":"Vargas JNS, Hamasaki M, Kawabata T, Youle RJ, Yoshimori T. The mechanisms and roles of selective autophagy in mammals. Nat Rev Mol Cell Biol. 2023;24:167\u201385.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8811_CR36","doi-asserted-by":"publisher","DOI":"10.1126\/science.adh5021","volume":"381","author":"X Gu","year":"2023","unstructured":"Gu X, Nardone C, Kamitaki N, Mao A, Elledge SJ, Greenberg ME. The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. Science. 2023;381:eadh5021.","journal-title":"Science"},{"key":"8811_CR37","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/s41586-024-07112-w","volume":"627","author":"P Xu","year":"2024","unstructured":"Xu P, Liu Y, Liu C, Guey B, Li L, Melenec P, et al. The CRL5-SPSB3 ubiquitin ligase targets nuclear cGAS for degradation. Nature. 2024;627:873\u20139.","journal-title":"Nature"},{"key":"8811_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade9585","volume":"9","author":"A Anandhan","year":"2023","unstructured":"Anandhan A, Dodson M, Shakya A, Chen J, Liu P, Wei Y, et al. NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8. Sci Adv. 2023;9:eade9585.","journal-title":"Sci Adv"},{"key":"8811_CR39","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/cr.2016.39","volume":"26","author":"KN Swatek","year":"2016","unstructured":"Swatek KN, Komander D. Ubiquitin modifications. Cell Res. 2016;26:399\u2013422.","journal-title":"Cell Res"},{"key":"8811_CR40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.tips.2018.12.004","volume":"40","author":"A Recasens","year":"2019","unstructured":"Recasens A, Munoz L. Targeting cancer cell dormancy. Trends Pharmacol Sci. 2019;40:128\u201341.","journal-title":"Trends Pharmacol Sci"},{"key":"8811_CR41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41568-023-00642-x","volume":"24","author":"J Agudo","year":"2024","unstructured":"Agudo J, Aguirre-Ghiso JA, Bhatia M, Chodosh LA, Correia AL, Klein CA. Targeting cancer cell dormancy. Nat Rev Cancer. 2024;24:97\u2013104.","journal-title":"Nat Rev Cancer"},{"key":"8811_CR42","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1158\/0008-5472.CAN-21-0933","volume":"82","author":"MC Heinz","year":"2022","unstructured":"Heinz MC, Peters NA, Oost KC, Lindeboom RGH, van Voorthuijsen L, Fumagalli A, et al. Liver colonization by colorectal cancer metastases requires YAP-controlled plasticity at the micrometastatic stage. Cancer Res. 2022;82:1953\u201368.","journal-title":"Cancer Res"},{"key":"8811_CR43","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nature20785","volume":"540","author":"H Hosseini","year":"2016","unstructured":"Hosseini H, Obradovi\u0107 MMS, Hoffmann M, Harper KL, Sosa MS, Werner-Klein M, et al. Early dissemination of seeds metastasis in breast cancer. Nature. 2016;540:552\u20138.","journal-title":"Nature"},{"key":"8811_CR44","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1172\/JCI96393","volume":"128","author":"I Puig","year":"2018","unstructured":"Puig I, Tenbaum SP, Chicote I, Arqu\u00e9s O, Mart\u00ednez-Quintanilla J, Cuesta-Borr\u00e1s E, et al. TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence. J Clin Investig. 2018;128:3887\u2013905.","journal-title":"J Clin Investig"},{"key":"8811_CR45","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201798772","volume":"37","author":"LB Hoang-Minh","year":"2018","unstructured":"Hoang-Minh LB, Siebzehnrubl FA, Yang C, Suzuki-Hatano S, Dajac K, Loche T, et al. Infiltrative and drug-resistant slow-cycling cells support metabolic heterogeneity in glioblastoma. EMBO J. 2018;37:e98772.","journal-title":"EMBO J"},{"key":"8811_CR46","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.210092","volume":"11","author":"P Bora","year":"2021","unstructured":"Bora P, Gahurova L, Hauserova A, Stiborova M, Collier R, Potesil D, et al. DDX21 is a p38-MAPK-sensitive nucleolar protein necessary for mouse preimplantation embryo development and cell-fate specification. Open Biol. 2021;11:210092.","journal-title":"Open Biol"},{"key":"8811_CR47","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/1878-0261.12906","volume":"15","author":"V Putra","year":"2021","unstructured":"Putra V, Hulme AJ, Tee AE, Sun JQJ, Atmadibrata B, Ho N, et al. The RNA-helicase DDX21 upregulates CEP55 expression and promotes neuroblastoma. Mol Oncol. 2021;15:1162\u201379.","journal-title":"Mol Oncol"},{"key":"8811_CR48","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1038\/s41388-024-03160-8","volume":"43","author":"W Tang","year":"2024","unstructured":"Tang W, Yang Y, Fu Z, Xu W, Ou W, Liu F, et al. The RNA helicase DDX21 activates YAP to promote tumorigenesis and is transcriptionally upregulated by \u03b2-catenin in colorectal cancer. Oncogene. 2024;43:3227\u201339.","journal-title":"Oncogene"},{"key":"8811_CR49","doi-asserted-by":"publisher","first-page":"12647","DOI":"10.1080\/21655979.2021.2011636","volume":"12","author":"K Wang","year":"2021","unstructured":"Wang K, Li B, Fan P, Ren X, Jiang H. Downregulation of DEAD-box helicase 21 (DDX21) inhibits proliferation, cell cycle, and tumor growth in colorectal cancer via targeting cell division cycle 5-like (CDC5L). Bioengineered. 2021;12:12647\u201358.","journal-title":"Bioengineered"},{"key":"8811_CR50","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/s41556-021-00784-w","volume":"23","author":"K Koltowska","year":"2021","unstructured":"Koltowska K, Okuda KS, Gloger M, Rondon-Galeano M, Mason E, Xuan J, et al. The RNA helicase Ddx21 controls Vegfc-driven developmental lymphangiogenesis by balancing endothelial cell ribosome biogenesis and p53 function. Nat Cell Biol. 2021;23:1136\u201347.","journal-title":"Nat Cell Biol"},{"key":"8811_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79049-9","volume":"10","author":"A Tanaka","year":"2020","unstructured":"Tanaka A, Wang JY, Shia J, Zhou Y, Ogawa M, Hendrickson RC, et al. DEAD-box RNA helicase protein DDX21 as a prognosis marker for early-stage colorectal cancer with microsatellite instability. Sci Rep. 2020;10:22085.","journal-title":"Sci Rep"},{"key":"8811_CR52","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.canlet.2018.08.021","volume":"437","author":"H Zhang","year":"2018","unstructured":"Zhang H, Zhang Y, Chen C, Zhu X, Zhang C, Xia Y, et al. A double-negative feedback loop between DEAD-box protein DDX21 and Snail regulates epithelial-mesenchymal transition and metastasis in breast cancer. Cancer Lett. 2018;437:67\u201378.","journal-title":"Cancer Lett"},{"key":"8811_CR53","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13058-018-1049-0","volume":"20","author":"E Borgen","year":"2018","unstructured":"Borgen E, Rypdal MC, Sosa MS, Renolen A, Schlichting E, L\u00f8nning PE, et al. NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients. Breast Cancer Res. 2018;20:120.","journal-title":"Breast Cancer Res"},{"key":"8811_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02023-w","volume":"23","author":"X Lin","year":"2024","unstructured":"Lin X, Kang K, Chen P, Zeng Z, Li G, Xiong W, et al. Regulatory mechanisms of PD-1\/PD-L1 in cancers. Mol Cancer. 2024;23:108.","journal-title":"Mol Cancer"},{"key":"8811_CR55","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13045-022-01294-4","volume":"15","author":"J Weng","year":"2022","unstructured":"Weng J, Li S, Zhu Z, Liu Q, Zhang R, Yang Y, et al. Exploring immunotherapy in colorectal cancer. J Hematol Oncol. 2022;15:95.","journal-title":"J Hematol Oncol"},{"key":"8811_CR56","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adl0165","volume":"10","author":"NR Richbourg","year":"2024","unstructured":"Richbourg NR, Irakoze N, Kim H, Peyton SR. Outlook and opportunities for engineered environments of breast cancer dormancy. Sci Adv. 2024;10:eadl0165.","journal-title":"Sci Adv"},{"key":"8811_CR57","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2407506121","volume":"121","author":"J-R Wei","year":"2024","unstructured":"Wei J-R, Zhang B, Zhang Y, Chen W-M, Zhang X-P, Zeng T-T, et al. QSOX1 facilitates dormant esophageal cancer stem cells to evade immune elimination via PD-L1 upregulation and CD8 T cell exclusion. Proc Natl Acad Sci USA. 2024;121:e2407506121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8811_CR58","doi-asserted-by":"publisher","first-page":"5850","DOI":"10.1158\/1078-0432.CCR-10-2574","volume":"17","author":"MS Sosa","year":"2011","unstructured":"Sosa MS, Avivar-Valderas A, Bragado P, Wen H-C, Aguirre-Ghiso JA. ERK1\/2 and p38\u03b1\/\u03b2 signaling in tumor cell quiescence: opportunities to control dormant residual disease. Clin Cancer Res. 2011;17:5850\u20137.","journal-title":"Clin Cancer Res"},{"key":"8811_CR59","doi-asserted-by":"publisher","first-page":"10519","DOI":"10.1073\/pnas.0800939105","volume":"105","author":"DM Schewe","year":"2008","unstructured":"Schewe DM, Aguirre-Ghiso JA. ATF6alpha-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo. Proc Natl Acad Sci USA. 2008;105:10519\u201324.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8811_CR60","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/carcin\/bgr241","volume":"33","author":"RJM Correa","year":"2012","unstructured":"Correa RJM, Peart T, Valdes YR, DiMattia GE, Shepherd TG. Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids. Carcinogenesis. 2012;33:49\u201358.","journal-title":"Carcinogenesis"},{"key":"8811_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2020.151096","volume":"99","author":"M Guereno","year":"2020","unstructured":"Guereno M, Delgado Pastore M, Lugones AC, Cercato M, Todaro L, Urtreger A, et al. Glypican-3 (GPC3) inhibits metastasis development promoting dormancy in breast cancer cells by p38 MAPK pathway activation. Eur J Cell Biol. 2020;99:151096.","journal-title":"Eur J Cell Biol"},{"key":"8811_CR62","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3892\/br.2025.2047","volume":"23","author":"K Sato","year":"2025","unstructured":"Sato K, Yoshino H, Sato Y, Sasaki F, Munakata N, Tsuruga E. Impact of the ATM\/Chk2 pathway and cell cycle phase on radiation-induced senescence in A549 human lung cancer cells. Biomed Rep. 2025;23:169.","journal-title":"Biomed Rep"},{"key":"8811_CR63","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3390\/cells10030610","volume":"10","author":"A Menegakis","year":"2021","unstructured":"Menegakis A, Klompmaker R, Vennin C, Arbus\u00e0 A, Damen M, van den Broek B, et al. Resistance of hypoxic cells to ionizing radiation is mediated in part via hypoxia-induced quiescence. Cells. 2021;10:610.","journal-title":"Cells"},{"key":"8811_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115388","volume":"44","author":"P Pereira","year":"2025","unstructured":"Pereira P, Panier J, Nater M, Herbst M, Calvanese AL, K\u00f6ksal H, et al. Inflammatory cytokines mediate the induction of and awakening from metastatic dormancy. Cell Rep. 2025;44:115388.","journal-title":"Cell Rep"},{"key":"8811_CR65","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2515009122","volume":"122","author":"J Zhang","year":"2025","unstructured":"Zhang J, Zhang J, Han L, Wu S, Li J, Eaton EN, et al. Inflammation awakens dormant cancer cells by modulating the epithelial-mesenchymal phenotypic state. Proc Natl Acad Sci USA. 2025;122:e2515009122.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8811_CR66","doi-asserted-by":"publisher","first-page":"11893","DOI":"10.3390\/ijms262411893","volume":"26","author":"M Bakir","year":"2025","unstructured":"Bakir M, Dabaliz A, Dawalibi A, Mohammad KS. Microenvironmental and molecular pathways driving dormancy escape in bone metastases. Int J Mol Sci. 2025;26:11893.","journal-title":"Int J Mol Sci"},{"key":"8811_CR67","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1007\/s00262-023-03481-9","volume":"72","author":"SM Ridwan","year":"2023","unstructured":"Ridwan SM, Emlein R, Mesbahi A, Annabi A, Hainfeld JF, Smilowitz HM. Radiation-induced dormancy of intracerebral melanoma: endotoxin inflammation leads to both shortened tumor dormancy and long-term survival with localized senescence. Cancer Immunol Immunotherapy. 2023;72:3851\u20139.","journal-title":"Cancer Immunol Immunotherapy"},{"key":"8811_CR68","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201911049","volume":"219","author":"DG Maranon","year":"2020","unstructured":"Maranon DG, Sharma N, Huang Y, Selemenakis P, Wang M, Altina N, et al. NUCKS1 promotes RAD54 activity in homologous recombination DNA repair. J Cell Biol. 2020;219:e201911049.","journal-title":"J Cell Biol"},{"key":"8811_CR69","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41419-023-06010-9","volume":"14","author":"S Zheng","year":"2023","unstructured":"Zheng S, Ji R, He H, Li N, Han C, Han J, et al. NUCKS1, a LINC00629-upregulated gene, facilitated osteosarcoma progression and metastasis by elevating asparagine synthesis. Cell Death Dis. 2023;14:489.","journal-title":"Cell Death Dis"},{"key":"8811_CR70","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1038\/s41388-023-02687-6","volume":"42","author":"H Gao","year":"2023","unstructured":"Gao H, Wei H, Yang Y, Li H, Liang J, Ye J, et al. Phase separation of DDX21 promotes colorectal cancer metastasis via MCM5-dependent EMT pathway. Oncogene. 2023;42:1704\u201315.","journal-title":"Oncogene"},{"key":"8811_CR71","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13046-023-02654-9","volume":"42","author":"N Zhang","year":"2023","unstructured":"Zhang N, Wang B, Ma C, Zeng J, Wang T, Han L, et al. LINC00240 in the 6p22.1 risk locus promotes gastric cancer progression through USP10-mediated DDX21 stabilization. J Exp Clin Cancer Res. 2023;42:89.","journal-title":"J Exp Clin Cancer Res"},{"key":"8811_CR72","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41419-024-07012-x","volume":"15","author":"G Zhang","year":"2024","unstructured":"Zhang G, Yang R, Wang B, Yan Q, Zhao P, Zhang J, et al. TRIP13 regulates progression of gastric cancer through stabilising the expression of DDX21. Cell Death Dis. 2024;15:622.","journal-title":"Cell Death Dis"},{"key":"8811_CR73","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13046-023-02609-0","volume":"42","author":"Y Liu","year":"2023","unstructured":"Liu Y, Xu Q, Deng F, Zheng Z, Luo J, Wang P, et al. HERC2 promotes inflammation-driven cancer stemness and immune evasion in hepatocellular carcinoma by activating STAT3 pathway. J Exp Clin Cancer Res. 2023;42:38.","journal-title":"J Exp Clin Cancer Res"},{"key":"8811_CR74","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401633","volume":"11","author":"Y Liu","year":"2024","unstructured":"Liu Y, Xu Q, Liu Y, Cao S, Luo J, Zheng Z, et al. Hepatocyte-targeted lipid nanoparticle delivery of HERC2 plasmid controls drug-induced hepatotoxicity by limiting \u03b2-catenin-regulated CYP2E1 expression. Adv Sci. 2024;11:e2401633.","journal-title":"Adv Sci"},{"key":"8811_CR75","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41419-025-07656-3","volume":"16","author":"A Song","year":"2025","unstructured":"Song A, Liu B, Li W, Chen B, Gui P, Zhang H, et al. Competitive binding between DDX21 and SIRT7 enhances NAT10-mediated ac4C modification to promote colorectal cancer metastasis and angiogenesis- DDX21 promotes colorectal cancer metastasis. Cell Death Dis. 2025;16:353.","journal-title":"Cell Death Dis"},{"key":"8811_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.216011","volume":"554","author":"J Feng","year":"2022","unstructured":"Feng J, Xi Z, Jiang X, Li Y, Nik Nabil WN, Liu M, et al. Saikosaponin A enhances Docetaxel efficacy by selectively inducing death of dormant prostate cancer cells through excessive autophagy. Cancer Lett. 2022;554:216011.","journal-title":"Cancer Lett"},{"key":"8811_CR77","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.2147\/DDDT.S494168","volume":"19","author":"SST Hnit","year":"2025","unstructured":"Hnit SST, Bi L, Xie C, Xu L, Zhong Y, Yang M, et al. Inhibition of dormant lung cancer cell reactivation by Punica granatum peel and Dioscorea nipponica: involving MYC, SKP2 and p27. Drug Des Devel Ther. 2025;19:3997\u20134010.","journal-title":"Drug Des Devel Ther"},{"key":"8811_CR78","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nbt.3836","volume":"35","author":"J Roper","year":"2017","unstructured":"Roper J, Tammela T, Cetinbas NM, Akkad A, Roghanian A, Rickelt S, et al. In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis. Nat Biotechnol. 2017;35:569\u201376.","journal-title":"Nat Biotechnol"},{"key":"8811_CR79","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1021\/pr501005v","volume":"14","author":"JT Galligan","year":"2014","unstructured":"Galligan JT, Martinez-No\u00ebl G, Arndt V, Hayes S, Chittenden TW, Harper JW, et al. Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. J Proteome Res. 2014;14:953\u201366.","journal-title":"J Proteome Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08811-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08811-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08811-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:03:15Z","timestamp":1782086595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08811-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,3]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8811"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08811-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,3]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study complied with the Declaration of Helsinki and the Basel Declaration. Protocols involving human subjects and their data were reviewed and approved by the Ethics Committee of the China-Japan Union Hospital of Jilin University (2022-KYYS-048), with informed consent obtained from all participants. All animal procedures were approved by the Animal Welfare and Ethics Committee of Fudan University and conducted in strict accordance with relevant guidelines (2023-FSYX-05JZS).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"588"}}